AgomAb Therapeutics NV ($AGMB)
Filing Information
| Accession Number | 0002119332-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 7, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
10,000
Total Value
$85,940.00
P&L
+7.3% (+$6,260.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common shares | โ | Oct 6, 2026 | Purchase | 3,000 | $8.67 | $26,010.00 | 3,000 | Direct | โ | View Details | |
Chief Financial Officer | Common shares | โ | Oct 6, 2026 | Purchase | 5,000 | $8.57 | $42,850.00 | 8,000 | Direct | โ | View Details | |
Chief Financial Officer | Common shares | โ | Oct 6, 2026 | Purchase | 2,000 | $8.54 | $17,080.00 | 10,000 | Direct | โ | View Details |